Literature DB >> 26739493

Hydrophobic motif site-phosphorylated protein kinase CβII between mTORC2 and Akt regulates high glucose-induced mesangial cell hypertrophy.

Falguni Das1, Nandini Ghosh-Choudhury2, Meenalakshmi M Mariappan1, Balakuntalam S Kasinath3, Goutam Ghosh Choudhury4.   

Abstract

PKCβII controls the pathologic features of diabetic nephropathy, including glomerular mesangial cell hypertrophy. PKCβII contains the COOH-terminal hydrophobic motif site Ser-660. Whether this hydrophobic motif phosphorylation contributes to high glucose-induced mesangial cell hypertrophy has not been determined. Here we show that, in mesangial cells, high glucose increased phosphorylation of PKCβII at Ser-660 in a phosphatidylinositol 3-kinase (PI3-kinase)-dependent manner. Using siRNAs to downregulate PKCβII, dominant negative PKCβII, and PKCβII hydrophobic motif phosphorylation-deficient mutant, we found that PKCβII regulates activation of mechanistic target of rapamycin complex 1 (mTORC1) and mesangial cell hypertrophy by high glucose. PKCβII via its phosphorylation at Ser-660 regulated phosphorylation of Akt at both catalytic loop and hydrophobic motif sites, resulting in phosphorylation and inactivation of its substrate PRAS40. Specific inhibition of mTORC2 increased mTORC1 activity and induced mesangial cell hypertrophy. In contrast, inhibition of mTORC2 decreased the phosphorylation of PKCβII and Akt, leading to inhibition of PRAS40 phosphorylation and mTORC1 activity and prevented mesangial cell hypertrophy in response to high glucose; expression of constitutively active Akt or mTORC1 restored mesangial cell hypertrophy. Moreover, constitutively active PKCβII reversed the inhibition of high glucose-stimulated Akt phosphorylation and mesangial cell hypertrophy induced by suppression of mTORC2. Finally, using renal cortexes from type 1 diabetic mice, we found that increased phosphorylation of PKCβII at Ser-660 was associated with enhanced Akt phosphorylation and mTORC1 activation. Collectively, our findings identify a signaling route connecting PI3-kinase to mTORC2 to phosphorylate PKCβII at the hydrophobic motif site necessary for Akt phosphorylation and mTORC1 activation, leading to mesangial cell hypertrophy.

Entities:  

Keywords:  diabetic nephropathy; mTOR complex; protein kinase C; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 26739493      PMCID: PMC4824156          DOI: 10.1152/ajpcell.00266.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  87 in total

Review 1.  Regulation of protein kinase C.

Authors:  A C Newton
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

2.  Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.

Authors:  Yuzuru Ohshiro; Ronald C Ma; Yutaka Yasuda; Junko Hiraoka-Yamamoto; Allen C Clermont; Keiji Isshiki; Kunimasa Yagi; Emi Arikawa; Timothy S Kern; George L King
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

3.  Unrestrained mammalian target of rapamycin complexes 1 and 2 increase expression of phosphatase and tensin homolog deleted on chromosome 10 to regulate phosphorylation of Akt kinase.

Authors:  Falguni Das; Nandini Ghosh-Choudhury; Nirmalya Dey; Chandi Charan Mandal; Lenin Mahimainathan; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

4.  Immunodeficiency in protein kinase cbeta-deficient mice.

Authors:  M Leitges; C Schmedt; R Guinamard; J Davoust; S Schaal; S Stabel; A Tarakhovsky
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

5.  EGFR signals to mTOR through PKC and independently of Akt in glioma.

Authors:  Qi-Wen Fan; Christine Cheng; Zachary A Knight; Daphne Haas-Kogan; David Stokoe; C David James; Frank McCormick; Kevan M Shokat; William A Weiss
Journal:  Sci Signal       Date:  2009-01-27       Impact factor: 8.192

Review 6.  Diabetic nephropathy: mechanisms of renal disease progression.

Authors:  Yashpal S Kanwar; Jun Wada; Lin Sun; Ping Xie; Elisabeth I Wallner; Sheldon Chen; Sumant Chugh; Farhad R Danesh
Journal:  Exp Biol Med (Maywood)       Date:  2008-01

7.  Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids.

Authors:  P A Craven; C M Davidson; F R DeRubertis
Journal:  Diabetes       Date:  1990-06       Impact factor: 9.461

8.  Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.

Authors:  Vanessa P Houde; Sophie Brûlé; William T Festuccia; Pierre-Gilles Blanchard; Kerstin Bellmann; Yves Deshaies; André Marette
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

9.  Association and direct activation of signal transducer and activator of transcription1alpha by platelet-derived growth factor receptor.

Authors:  G G Choudhury; N Ghosh-Choudhury; H E Abboud
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

10.  Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes.

Authors:  Kai Mao; Satoru Kobayashi; Zahara M Jaffer; Yuan Huang; Paul Volden; Jonathan Chernoff; Qiangrong Liang
Journal:  J Mol Cell Cardiol       Date:  2007-12-03       Impact factor: 5.000

View more
  9 in total

1.  Tyrosines-740/751 of PDGFRβ contribute to the activation of Akt/Hif1α/TGFβ nexus to drive high glucose-induced glomerular mesangial cell hypertrophy.

Authors:  Falguni Das; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  Cell Signal       Date:  2017-09-23       Impact factor: 4.315

2.  PDGF receptor-β uses Akt/mTORC1 signaling node to promote high glucose-induced renal proximal tubular cell collagen I (α2) expression.

Authors:  Falguni Das; Nandini Ghosh-Choudhury; Balachandar Venkatesan; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-19

Review 3.  Metabolic Regulation of the Immune Humoral Response.

Authors:  Mark Boothby; Robert C Rickert
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

4.  Deacetylation of S6 kinase promotes high glucose-induced glomerular mesangial cell hypertrophy and matrix protein accumulation.

Authors:  Falguni Das; Soumya Maity; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2019-04-26       Impact factor: 5.157

Review 5.  Targeting mTOR in the Context of Diet and Whole-body Metabolism.

Authors:  Nikos Koundouros; John Blenis
Journal:  Endocrinology       Date:  2022-06-01       Impact factor: 5.051

Review 6.  The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.

Authors:  Jessica Lawrence; Richard Nho
Journal:  Int J Mol Sci       Date:  2018-03-08       Impact factor: 5.923

7.  Akt2 causes TGFβ-induced deptor downregulation facilitating mTOR to drive podocyte hypertrophy and matrix protein expression.

Authors:  Falguni Das; Nandini Ghosh-Choudhury; Doug Yoon Lee; Yves Gorin; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  PLoS One       Date:  2018-11-16       Impact factor: 3.240

Review 8.  Reprogramming of fatty acid metabolism in cancer.

Authors:  Nikos Koundouros; George Poulogiannis
Journal:  Br J Cancer       Date:  2019-12-10       Impact factor: 7.640

Review 9.  A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives.

Authors:  Zhongyu Han; Kuai Ma; Hongxia Tao; Hongli Liu; Jiong Zhang; Xiyalatu Sai; Yunlong Li; Mingxuan Chi; Qing Nian; Linjiang Song; Chi Liu
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.